Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00520338
Status:
COMPLETED
Last Update Posted:
2010-11-09
First Post:
2007-08-22
Brief Title:
Celecoxib for Reducing Morphine Requirement After Thyroid Surgery A Randomized Controlled Trial
Sponsor:
Mahidol University
Organization:
Mahidol University
Study Overview
Official Title:
Celecoxib for Reducing Morphine Requirement After Thyroid Surgery A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether celecoxib is effective in the treatment postoperative pain after thyroidectomy
The research hypothesis
There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib or placebo
The research hypothesis
There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib or placebo
Detailed Description:
Postoperative pain has been concerned in the past few years by both the anesthesiologists ans the surgeons COX2-inhibitors have played an important roles in postoperative pain with minimal side effects
Comparisons There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib and placebo
Comparisons There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib and placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None